Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-27

Clinical Trial Update: Real-world Effectiveness of Ustekinumab in Participants Suffering From Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis) With Extra-intestinal Manifestations or Immune-mediated Inflammatory Diseases

View source ↗

Summary

Real-world study evaluating the effectiveness of ustekinumab in patients with inflammatory bowel disease (Crohn's disease or ulcerative colitis) with extra-inte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Stelara (ustekinumab)

Snippet

Sponsor: Janssen Cilag S.A.S. | Conditions: Crohn Disease, Colitis, Ulcerative | Status: COMPLETED